Literature DB >> 1651436

[Coincidence of Gaucher disease with primary hepatocellular carcinoma].

C M Breiden-Langen1, R Büchsel, H J Brambs, M Oehlert, S Matern.   

Abstract

Case report on a 48-year-old man with Gaucher's disease and a HBsAg-positive cirrhosis simultaneously. Postmortem examination revealed a hepatocellular carcinoma suggested by antecedent ultrasound examination. The coexistence of Gaucher's disease and hepatocellular carcinoma has not been described before. A possible relationship between Gaucher's disease and hepatocellular carcinoma is supposed due to Gaucher's disease and association to the hepatitis B infection.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1651436

Source DB:  PubMed          Journal:  Leber Magen Darm        ISSN： 0300-8622


  4 in total

Review 1.  Gaucher disease: new developments in treatment and etiology.

Authors:  Ozgur Harmanci; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

2.  Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process.

Authors:  H Hůlková; J Ledvinová; H Poupetová; A Kohout; V Malinová; M Elleder
Journal:  J Inherit Metab Dis       Date:  2009-06-26       Impact factor: 4.982

3.  Hepatocellular carcinoma in Gaucher disease: an international case series.

Authors:  Martine Regenboog; Laura van Dussen; Joanne Verheij; Neal J Weinreb; David Santosa; Stephan Vom Dahl; Dieter Häussinger; Meike N Müller; Ali Canbay; Miriam Rigoldi; Alberto Piperno; Tama Dinur; Ari Zimran; Pramod K Mistry; Karima Yousfi Salah; Nadia Belmatoug; David J Kuter; Carla E M Hollak
Journal:  J Inherit Metab Dis       Date:  2018-02-08       Impact factor: 4.982

4.  Liver fibrosis in type I Gaucher disease: magnetic resonance imaging, transient elastography and parameters of iron storage.

Authors:  Anneloes E Bohte; Laura van Dussen; Erik M Akkerman; Aart J Nederveen; Ralph Sinkus; Peter L M Jansen; Jaap Stoker; Carla E M Hollak
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.